June 6, 2024
Today, the FDA rescinded its June 2022 Marketing Denial Orders (MDOs) for the JUUL System and placed our applications back into scientific review. We appreciate the FDA’s decision and now look forward to re-engaging with the agency on a science- and evidence-based process to pursue a marketing authorization for JUUL products.
December 19, 2023
Juul Labs has taken another important step in its path forward to introduce novel technologies that provide adult smokers an alternative to combustible cigarettes…
October 4, 2023
At a time when underage use of JUUL products has been cut by 95%, while usage of illicit disposable vapes from China is skyrocketing, it is disappointing to see the Florida Attorney General direct her state’s resources to suing Juul Labs.
September 28, 2023
This week, Juul Labs Chief Regulatory Officer, Joe Murillo, delivered remarks at the 76th Tobacco Science Research Conference, where he discussed the current state…
August 23, 2023
Today, JLI is announcing a company restructuring aimed at reducing our operating costs and positioning us to continue to advance our mission during a…
July 19, 2023
Juul Labs today announced the submission of the first Premarket Tobacco Product Application (PMTA) for the company’s next-generation vapor platform to the U.S. Food and Drug Administration (FDA).
April 17, 2023
Resolution of issues from the company’s past and its historical legal challenges has remained a critical priority to secure certainty for our future. While…
April 12, 2023
This settlement with seven state attorneys general represents another critical part in our ongoing commitment to resolve issues from the company’s past. The terms…
April 10, 2023
This settlement with the West Virginia Attorney General represents yet another step in Juul Labs’ ongoing commitment to resolve issues from the company’s past….
March 3, 2023
The return of Altria’s equity stake and termination of underlying agreements affords us full strategic freedom – we are no longer limited by the…